🇺🇸 FDA

Intelligence · Patent portfolio

Paxlovid Patents

Full USPTO pharma patent portfolio for Paxlovid — grant dates, expiration, and drug cross-links.

Patents
193
Expiring ≤24m
2

Quick answer

Paxlovid has 193 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 2 expire within 24 months — use filters for patent-cliff planning.

Page 4 of 5

  1. US 8883185

    Hydrogel implants with varying degrees of crosslinking

    Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8875970

    Structure containing wound treatment material

    Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8835513

    Drug delivery devices

    Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8834418

    Molds for in situ forming materials

    Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8758799

    Therapeutic implant

    Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8758800

    Therapeutic implant

    Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8758798

    Therapeutic implant

    Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8754564

    Hydrogel implants with varying degrees of crosslinking

    Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8734930

    Hydrogel implants with varying degrees of crosslinking

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8734825

    Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8734824

    Hydrogel implants with varying degrees of crosslinking

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8672906

    Medical dressing containing antimicrobial agent and related methods therefor

    Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8673332

    Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens

    Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8668924

    Wound dressing and method for controlling severe, life-threatening bleeding

    Expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8652836

    Defective ribosomal products in blebs (DRibbles) and methods of use to stimulate an immune response

    Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8632839

    Methods of forming self-supporting films for delivery of therapeutic agents

    Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8616429

    Structure containing wound treatment material

    Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8598312

    Inhibitors of antigen presentation by MHC class II molecules

    Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8591929

    Hydrogel implants with varying degrees of crosslinking

    Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8591950

    Hydrogel implants with varying degrees of crosslinking

    Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8563023

    Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens

    Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8548557

    Medical electrodes

    Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8518440

    Biodegradable osmotic pump implant for drug delivery

    Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8475828

    Medical apparatus and method for producing same

    Expires Mon Jun 27 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8444612

    Self contained wound dressing apparatus

    Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8440309

    Crosslinked polymers with the crosslinker as therapeutic for sustained release

    Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8360765

    Systems and method for forming a coaxial implant

    Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8357361

    Bioabsorbable surgical composition

    Expires Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8349987

    Adhesive formulations

    Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8329205

    Bioabsorbable composition and coatings of a fatty acid salt, epsilon-caprolactone, a monomer, and homopolymers or copolymers

    Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8322588

    Structure containing wound treatment material

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8222215

    Methods for the use of inhibitors of antigen presentation by MHC class II molecules

    Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8202242

    Method of using vasoconstrictive agents during energy-based tissue therapy

    Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8163297

    Live attenuated aldolase-negative bacterial vaccine

    Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8076451

    Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally sensitive transmembrane peptide

    Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7959925

    Trimeric OX40-immunoglobulin fusion protein and methods of use

    Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7799753

    Bisubstrate inhibitors of protein tyrosine kinases as therapeutic agents

    Expires Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7767686

    Method of using adenosine receptor blockers during tissue ablation

    Expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7622444

    Methods for using OX-40 ligand to enhance an antigen specific immune response

    Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7504101

    Methods for enhancing antigen-specific immune response using antibodies that bind OX-40

    Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7439231

    Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof

    Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7371403

    Wound dressing and method for controlling severe, life-threatening bleeding

    Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7202087

    Anticoagulant composition

    Expires Mon Apr 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 6913757

    Live, avirulent strain of V. anguillarum that protects fish against infection by virulent V. anguillarum and method of making the same

    Expires Mon Jun 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  45. US 6372228

    Method of producing elastin, elastin-based biomaterials and tropoelastin materials

    Expires Mon Apr 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  46. US 6312915

    Tick (Ixodes scapularis) vector saliva-induced Lyme disease spirochete (Borrelia burgdorferi) antigens as vaccine candidates

    Expires Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  47. US 6262064

    Octahydrobenzo[f]quinoline-based receptor agonists and antagonists

    Expires Mon Jul 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  48. US 6106856

    Transdermal delivery of calcium channel blockers, such as nifedipine

    Expires Mon Aug 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Paxlovid have?

193 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Paxlovid patents expire?

2 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.